Line chart: IQVIA Free Cash Flow for IQVIA. Q4 2020-Q2 2026, values in usd_millions. Free cash flow: 574 in Q4 2020 to 360 in Q2 2026, peaking at 772 in Q3 2025.
Free cash flow
IQVIA R&D Solutions Contracted Backlog
Line chart: IQVIA R&D Solutions Contracted Backlog for IQVIA. Q4 2019-Q2 2026, values in usd_billions. Contracted backlog: 19 in Q4 2019 to 34.2 in Q2 2026.
Contracted backlog
IQVIA R&D Solutions Book-to-Bill
Line chart: IQVIA R&D Solutions Book-to-Bill for IQVIA. Q4 2019-Q2 2026, values in ratio. Book-to-bill: 1.46 in Q4 2019 to 1.22 in Q2 2026, peaking at 1.71 in Q3 2020.
Book-to-bill
IQVIA R&D Solutions Net New Bookings
Line chart: IQVIA R&D Solutions Net New Bookings for IQVIA. Q1 2023-Q2 2026, values in usd_billions. Net new bookings: 2.6 in Q1 2023 to 3.15 in Q2 2026.
Net new bookings
Employee Count
Line chart: Employee Count for IQVIA. 2013-2025. Employees: 28,200 in 2013 to 93,000 in 2025.
Employees
Revenue by Product/Service
Bar chart: Revenue by Product/Service for IQVIA. 2021-Q3-2026-Q2, values in B. In 2026-Q2: Technology & Analytics Solutions 3.547, Research & Development Solutions 2.575, Contract Sales & Medical Solutions 0, Product Development 0, Healthcare Services 0.
Revenue by Geography
Bar chart: Revenue by Geography for IQVIA. 2021-Q3-2026-Q2, values in B. In 2026-Q2: Americas 2.039, EMEA 1.409, Asia Pacific 0.92.